Stopping High-Efficacy MS Drugs Raises Relapse Risk for Older Patients

(MedPage Today) -- Patients ages 50 or older with non-active multiple sclerosis (MS) who discontinued high-efficacy therapy (HET) had a higher risk of relapse compared with those who continued HET, a matched observational cohort study found. Time...
Source: MedPage Today Neurology - Category: Neurology Source Type: news